VitaDAO (VITA) is a decentralised autonomous organisation (DAO) dedicated to funding and accelerating research in the longevity space. Its mission is to extend human lifespan by democratising the funding, ownership, and commercialisation of therapeutics through community-driven governance.
VitaDAO operates on the Ethereum blockchain, utilising smart contracts to manage governance and token-based voting. Key features include:
VitaDAO bridges the gap between research and commercialisation by fostering collaboration between researchers, investors, and the broader community.
VitaDAO supports applications in biotechnology, decentralised science (DeSci), and intellectual property management, such as:
Key industries include biotechnology, pharmaceuticals, decentralised science, and DeFi.
VitaDAO was founded in 2021 as a spin-off from Molecule’s decentralised framework, addressing the limitations of traditional funding models for longevity research.
VitaDAO has established itself as a key player in decentralised science, leveraging blockchain technology for innovative funding and IP management. Its partnerships with academic labs and pharmaceutical companies, including Pfizer, highlight its growing influence in the longevity and biopharma sectors.
VitaDAO continues to evolve, attracting stakeholders across academia, industry, and decentralised ecosystems to drive the future of longevity research.